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Microenvironments appear important in stem
cell lineage specification but can be difficult to
adequately characterize or control with soft tis-
sues. Naive mesenchymal stem cells (MSCs)
are shownhere to specify lineage and commit to
phenotypes with extreme sensitivity to tissue-
level elasticity. Soft matrices that mimic brain
are neurogenic, stiffer matrices that mimicmus-
cle are myogenic, and comparatively rigid
matrices that mimic collagenous bone prove
osteogenic. During the initial week in culture,
reprogramming of these lineages is possible
with addition of soluble induction factors, but
after several weeks in culture, the cells commit
to the lineage specified by matrix elasticity,
consistent with the elasticity-insensitive com-
mitment of differentiated cell types. Inhibition
of nonmuscle myosin II blocks all elasticity-
directed lineage specification–without strongly
perturbing many other aspects of cell function
and shape. The results have significant implica-
tions for understanding physical effects of the
in vivomicroenvironment and also for therapeu-
tic uses of stem cells.
INTRODUCTION
Adult stem cells, as part of normal regenerative pro-
cesses, are believed to egress and circulate away from
their niche (Katayama et al., 2006), and then engraft and
differentiate within a range of tissue microenvironments.
The tissue or matrix microenvironments can be as physi-
cally diverse as those of brain, muscle, and bone precur-
sor osteoid (respectively, Flanagan et al. 2002; Georges
et al., 2006; Kondo et al., 2005, Engler et al., 2004a; Ferrari
et al., 1998; Andrades et al., 2001; Holmbeck et al., 1999;
Morinobu et al., 2003). Mesenchymal stem cells (MSCs)
are marrow-derived and have indeed been reported todifferentiate into various anchorage-dependent cell types,
including neurons, myoblasts, and osteoblasts (respec-
tively, [Deng et al., 2005; Hofstetter et al., 2002; Kondo
et al., 2005], [Pittenger et al., 1999], and [McBeath et al.,
2004; Pittenger et al., 1999]). For differentiated cells
such as fibroblasts, it is well known that responses to
the typical soluble inducers such as growth factors couple
to matrix anchorage (Nakagawa et al., 1989). However,
with naive stem cells, direct effects of matrix physical at-
tributes such as matrix stiffness have yet to be examined.
Differentiated cells ranging from neurons to osteoblasts
adhere, contract, and crawl not only within soft tissues
such as that of the brain or on top of crosslinked collagen
‘‘osteoids’’ in remodeling bone but also in vitro on colla-
gen-coated acrylamide gels and glass (Figure 1A). Such
a wide variation in matrix stiffness for differentiated cells
is known to influence focal-adhesion structure and the
cytoskeleton (Bershadsky et al., 2003; Cukierman et al.,
2001; Discher et al., 2005; Engler et al., 2004a; Lo et al.,
2000; Pelham and Wang, 1997). Past results with cells
committed to a particular lineage, especially fibroblasts,
on floating collagen gels and wrinkling-silicone sheets
also suggest some responsiveness to the physical state
of the matrix (Hinz et al., 2001; Nakagawa et al., 1989;
Tomasek et al., 2002; Wozniak et al., 2003), but gel poros-
ity and film topography complicate identification of possi-
ble contributions of substrate stiffness. In contrast, tissue-
level matrix stiffness is distinct and shown here in sparse
cultures to exert very strong effects on the lineage speci-
fication and commitment of naive MSCs, as evident in cell
morphology, transcript profiles, marker proteins, and the
stability of responses.
How might MSCs ‘‘feel’’ or sense matrix elasticity and
transduce that information into morphological changes
and lineage specification? At the molecular scale, matrix
sensing first requires the ability to pull against the matrix
and, secondly, requires a cellular mechano-transducer(s)
to generate signals based on the force that the cell must
generate to deform the matrix. Of the cell’s cytoskeletal
motors, one or all of the nonmuscle myosin II isoforms
(NMM IIA, B, and C [Kim et al., 2005]) are candidates, as
they are implicated in tensioning cortical actin structuresCell 126, 677–689, August 25, 2006 ª2006 Elsevier Inc. 677
Figure 1. Tissue Elasticity and Differenti-
ation of Naive MSCs
(A) Solid tissues exhibit a range of stiffness, as
measured by the elastic modulus, E.
(B) The in vitro gel system allows for control of
E through crosslinking, control of cell adhesion
by covalent attachment of collagen-I, and con-
trol of thickness, h. Naive MSCs of a standard
expression phenotype (Table S1) are initially
small and round but develop increasingly
branched, spindle, or polygonal shapes when
grown on matrices respectively in the range
typical of Ebrain (0.1–1 kPa), Emuscle (8–
17 kPa), or stiff crosslinked-collagen matrices
(25–40 kPa). Scale bar is 20 mm. Inset graphs
quantify the morphological changes (mean ±
SEM) versus stiffness, E: shown are (i) cell
branching per length of primarymouse neurons
(Flanagan et al., 2002), MSCs, and blebbista-
tin-treated MSCs and (ii) spindle morphology
of MSCs, blebbistatin-treated MSCs, and
mitomycin-C treated MSCs (open squares)
compared to C2C12 myoblasts (dashed line)
(Engler et al., 2004a).
(C) Microarray profiling of MSC transcripts in
cells cultured on 0.1, 1, 11, or 34 kPa matrices
with or without blebbistatin treatment. Results
are normalized to actin levels and then normal-
ized again to expression in naive MSCs, yield-
ing the fold increase at the bottom of each
array. Neurogenic markers (left) are clearly
highest on 0.1–1 kPa gels, while myogenic
markers (center) are highest on 11 kPa gels
and osteogenic markers (right) are highest on
34 kPa gels. Blebbistatin blocks such specifi-
cation (<2-fold different from naive MSCs).(McBeath et al., 2004; Wang et al., 2002). These actin
structures are in turn linked to focal adhesions that provide
the pathway of force transmission from inside the cell to
the elastic matrix (Beningo et al., 2001; Tamada et al.,
2004) and associated with the focal-adhesion complexes
are a number of well-known signaling molecules that are
well-placed to act as the mechano-transducers (Bershad-678 Cell 126, 677–689, August 25, 2006 ª2006 Elsevier Inc.sky et al., 2003; Alenghat and Ingber, 2002). With MSCs
here, we demonstrate that one or all of the NMM IIA–C
are likely to be involved in the matrix-elasticity sensing
that drives lineage specification.
The resistance that a cell feels when it deforms the ECM
is measured by the elastic constant, E, of the matrix or mi-
croenvironment. Formicroenvironments of relevance here,
that of the brain (Flanagan et al., 2002) is considerably
softer than muscle (Engler et al., 2004a), and muscle is
softer than collagenous osteoid precursors of bone (mea-
sured here). Thewide range ofmicroenvironment elasticity
highlighted in Figure 1A is central, we show, to predicting
specification ofMSCs.Matrix elasticity ismimicked in vitro
herewith inert polyacrylamide gels inwhich the concentra-
tion of bis-acrylamide crosslinking sets the elasticity (Pel-
ham and Wang, 1997), and adhesion is provided by coat-
ing the gels with collagen I, which is known to support
myogenic and osteogenic differentiation (Engler et al.,
2004a; Garcia and Reyes, 2005). Using this well-defined,
elastically tunable gel system (Figure 1B), as opposed to
wrinkling films or degrading collagen gels (Hinz et al.,
2001; Wozniak et al., 2003), we provide the first evidence
with sparse cultures of MSCs that matrix can specify line-
age toward neurons, myoblasts, and osteoblasts—all in
identical serum conditions. We document the matrix regu-
lation of key lineagemarkers andmyosins, including NMM
IIs, which—when inhibited with blebbistatin (Straight et al.,
2003)—blocks differentiation. We also show that soluble
induction factors tend to be less selective thanmatrix stiff-
ness in driving specification, and cannot reprogramMSCs
that are precommitted for weeks on a givenmatrix. Finally,
by controlling gel thickness, h, we establish how far stem
cells can feel and thus physically define their micro-
environment.
RESULTS
Cell Morphology Suggests Lineage Specification
Is Directed by Matrix Stiffness and Dependent
on Nonmuscle Myosin II
On soft, collagen-coated gels that mimic brain elasticity
(Ebrain 0.1–1 kPa) (Flanagan et al., 2002), the vast major-
ity of MSCs adhere, spread, and exhibit an increasingly
branched, filopodia-rich morphology (Figure 1B). Branch-
ing densities after 1 week in culture approach those of pri-
mary neurons on matrigel-coated gels (Flanagan et al.,
2002), and the dynamics of outward extension with
branching is clearly opposite to DMSO-induced retraction
of the cell body that can leave pseudoextensions behind
(Neuhuber et al., 2004). MSCs on 10-fold stiffer matrices
that mimic striated muscle elasticity (Emuscle  8–17 kPa)
lead to spindle-shaped cells similar in shape to C2C12
myoblasts (Engler et al., 2004a). Stiffer matrices (25–40
kPa) that we show below mimic the crosslinked collagen
of osteoids (Garcia and Reyes, 2005; Kong et al., 2005)
yield polygonal MSCs similar in morphology to osteo-
blasts. Analyses of cell morphologies (Figure 1B; plots i
and ii) show that matrix-dependent shape variations of
MSCs are similar to differentiated cells. It is important to
also note in these plots and elsewhere below that the re-
sults with stiff acrylamide gels extrapolate to those with
collagen-coated, rigid glass; this is expected if substrate
elasticity is a key variable of importance. Furthermore,
since the inhibition of proliferation by mitomycin-C (opensquares, Figure 1B; plot ii) has little impact on average
cell shape, the morphology results are consistent with lin-
eage development being a population-level response to
substrate elasticity.
As introduced above, nonmuscle myosin II is likely to be
involved in exerting force through focal adhesions in
mechanisms of sensing matrix elasticity. All of the NMM
II isoforms are inhibited by blebbistatin, which does not
inhibit any other myosin found in MSCs (see below), other
than myosin VI (Limouze et al., 2004). Addition of blebbis-
tatin during plating blocks branching, elongation, and
spreading of MSCs on any substrate (Figure 1B; plots);
however, addition of blebbistatin 24 hr postplating does
not significantly reverse cell shape or spreading on Emuscle
gels after the cells have already spread and adopted a
spindle morphology (e.g., 24 hr per Figure 1B). Less spe-
cific and less potent myosin inhibitors such as BDM
(at mM concentrations) are already known to block neu-
ronal motility as well as the sensitivity of differentiated
cells to substrate elasticity (Pelham and Wang, 1997),
but blebbistatin is far more selective and potent (Straight
et al., 2003). It inhibits actin activation of NMM II ATPase
activity (at mM concentrations) and blocks migration
and cytokinesis in vertebrate cellswithout affectingMLCK.
Crystal structures show inhibition of actin-activated
ATPase activity by blebbistatin (Allingham et al., 2005)
requires a specific alanine (or serine) residue that is found
only in class II and VI myosins (Limouze et al., 2004;
Straight et al., 2003). We confirm below that MSCs ex-
press the three NMM IIs and myosin VI, but we implicate
NMM IIs and the cytoskeleton as critical to differentiation.
To reinforce this conclusion and to rule out a role for my-
osin VI in matrix sensing, we repeated the above experi-
ments with the myosin light chain kinase (MLCK) inhibitor,
ML7 (Dhawan and Helfman, 2004). Of the myosins found
in MSCs thusfar (see below), regulatory light chain phos-
phorylation via MLCK is only used to activate the NMM
IIs. ML7 will block activation of these as well as smooth
muscle myosin isoforms but will not affect activation of
any othermyosins inMSCs. Results withML7 prove below
to be identical to those seen with blebbistatin, and so
NMM II activity appears to be necessary for matrix elastic-
ity-driven lineage specification.
RNA Profiles Indicate Lineage Specification
on Matrices of Tissue-like Stiffness
Transcriptional profiles of neurogenic, myogenic, and
osteogenic markers—from early commitment markers
throughmid/late developmentmarkers—prove consistent
with indications from morphology. On the softest gels,
MSCs show the greatest expression of neurogenic tran-
scripts (Figure 1C, left column; Table S3). Neuron-specific
cytoskeletal markers such as nestin, an early commitment
marker, and b3 tubulin, expressed in immature neurons,
as well as the mature marker neurofilament light chain
(NFL) (Lariviere and Julien, 2004) and the early/midadhe-
sion protein NCAM (Rutishauser, 1984), are all upregu-
lated. In terms of a simple average across various keyCell 126, 677–689, August 25, 2006 ª2006 Elsevier Inc. 679
neurogenic transcripts, upregulation on the softest gels is
5-fold above early passage MSCs. On moderately stiff
matrices near Emuscle (11 kPa), MSCs express 6-fold
more myogenic message, with clear upregulation of early
to late transcriptional proteins such as Pax activators and
myogenic factors (e.g., MyoD); comparisons of expres-
sion levels to committed muscle cells are also provided
below. On the stiffest matrices (34 kPa), MSCs express
4-fold greater osteogenic message, upregulating osteo-
calcin and the early transcriptional factor CBFa1 (middle
and right column, respectively). Importantly, transcrip-
tional profiles of early versus late MSCs (up to passage
12) do not differ significantly (Table S1), even though
population expansion has been suggested by others to
dramatically alter MSCs (Maitra et al., 2005). However,
lineage specification on each matrix is clearly blebbistatin
sensitive (Figure 1C + blebbistatin).
A number of terminal differentiation markers such as
lineage specific integrins (a3, a7, and b1D) andmorphoge-
netic proteins are not upregulated relative to naive MSCs.
However, these are generally not expressed until later de-
velopment, e.g., cell fusion into myotubes is required for
b1D expression. Matrix stiffness undoubtedly couples to
cell density for fusion and synaptogenesis as well as other
noncollagenous ECM components and soluble factors
(see below).
Clarifying Neuro-Induction and Osteogenic
Microenvironments
The results above and that follow below provide insight
into the NMM II-based contractility and considerable sen-
sitivity of stem cells to mechanical microenvironment,
which are important issues in and of themselves, but the
results also bring to the fore several questions in the liter-
ature regarding induction strategies and the physical
nature of in vivo microenvironments. For example, uncer-
tainty exists regarding the inducibility of stem cells toward
neurogenic lineages. Soluble agonists such as retinoic
acid and dimethylsulfoxide (DMSO) have been reported
to induce reversible branching in stem cells (Dinsmore
et al., 1996;Woodbury et al., 2002), but DMSOalso causes
fibroblasts to appear ‘‘branched,’’ and this appears due to
cytoskeletal disruption with centripetal retraction of the
cell body that leaves extensions attached (Neuhuber
et al., 2004).
The time series of images in Figure 1B shows outwardly
branching MSCs on the softest gels (0.1–1 kPa) which, in
immunofluorescence (Figure 2A), also show expression
and branch localization of neuron-specific b3 tubulin and
neurofilament heavy chain (NFH and its phosphoform,
P-NFH). The latter are widely recognized as late neuronal
markers (Lariviere and Julien, 2004). Indeed, both MSCs
and primary neurons (Flanagan et al., 2002) spread and
branchwith time on the softestmatrices (Figure 2B), unlike
fibroblasts that do not branch or express neurogenic pro-
teins. Similarly, on myogenic matrices, both MSCs and
myoblasts spread and become spindle shaped with
time, unlike fibroblasts (Figure S1A). Intensity analyses of680 Cell 126, 677–689, August 25, 2006 ª2006 Elsevier Inc.immunofluorescent images (e.g., Figures 2A and 2C) as
well as Western blots (Figure 2C; inset) confirm that only
cells on the softest matrices express protein markers for
neuronal commitment (nestin), immature neurons (b3 tu-
bulin), mid/late neurons (microtubule associated protein
2; MAP2), and even mature neurons (NFL, NFH, and
P-NFH). These findings clearly agree with neurogenesis
of MSCs, as seen in more complex microenvironments,
especially the brain (Kondo et al., 2005; Wislet-Gendebien
et al., 2005).
Uncertainty also exists in the literature regarding the
compliance and thickness of osteoid. This crosslinked
collagen precursor to bone is secreted by osteoblasts
and reportedly is the matrix upon which MSCs undergo
a transition to preosteoblasts (Figure 2D) (Andrades
et al., 2001; Morinobu et al., 2003; Raisz, 1999), before
the matrix calcificies over week(s) (Rattner et al., 2000)
to rigid bone (106 kPa). We have made the first mea-
surements here of the compliance and thickness of the
osteocalcin-rich osteoid matrix (Figure 2E) that surrounds
osteoblasts in culture (see AFM in Experimental Proce-
dures). The matrix is 350 ± 100 nm thick (Figure 2F) and
has a stiffness, Eosteoid  27 ± 10 kPa (Figure 2G), that is
similar to a concentrated collagen gel (Roeder et al.,
2002). Osteoid thus possesses stiffness in the same range
that we find MSCs take on the shape and expression
profiles of an osteogenic lineage (25–40 kPa in Figures
1B and 1C).
Cytoskeletal Markers and Transcription Factors
also Indicate Lineage Specification
Immunostaining of cytoskeletal markers and transcription
factors across the range of matrix stiffnesses (Figure 3A)
proves consistent with the lineage profiling of Figure 1.
On the softest, neurogenic matrices, a majority of cells ex-
press b3 tubulin, which, along with P-NFH and NFH, is vis-
ible in long, branched extensions but is poorly expressed,
if at all, in cells on stiffer gels (Figure 2C). On moderately
stiff, myogenic matrices, MSCs upregulate the transcrip-
tion factor MyoD1, localizing it to the nucleus (large arrow;
Figure 3A). Compared with C2C12 myoblasts, transcript
levels (Figure 3B; Table S3) as well as fluorescence inten-
sity analyses (Figure 3C) indicate about 50% relative ex-
pression levels after 1 week on the myogenic matrix;
MSCs on softer and stiffer matrices do not express signif-
icant MyoD1 or other muscle markers (e.g., titin, pax-3,7,
and myogenin). On the stiffest, osteogenic matrices,
MSCs upregulate the transcription factor CBFa1 (Fig-
ure 3A; open arrow), which is a crucial early marker of
osteogenesis (Gilbert et al., 2002). Compared with hFOB
osteoblasts, transcript levels (Figure 3B; Table S3) as
well as fluorescence intensity analyses (Figure 3C) again
indicate about 50% relative expression levels after 1
week on the osteogenic matrix; MSCs on softer matrices
do not express significant CBFa1 or other osteoblast
markers (e.g., collagen-1s and BMPs).
Elasticity-directed marker protein expression on the
various substrates is summarized in Figure 3C. A single,
Figure 2. Neurogenic Branching and Osteogenic Microenvironments
(A) Immunofluorescence images of b3 tubulin and NFH in branched extensions of MSCs on soft matrices (E  1 kPa). Scale bars are 5 mm.
(B) MSCs and fibroblasts on a range of elastic matrices show an increase in projected area with matrix stiffness, but only MSCs on the softest gels
(with smallest areas) show an increasing number of branches per extension length with time.
(C) b3 tubulin, NFH, and P-NFH all localize to the branches of MSCs on the softest substrates with E < 1 kPa (mean ± SEM). Nestin, b3 tubulin, MAP2,
and NFL Western blotting (inset) confirms expression only on soft gels.
(D) Schematic of the compliant, collagenous ‘‘osteoid’’ microenvironment (green) that MSCs encounter in initial remodeling of bone matrix (adapted
from Raisz, 1999). Committed osteoblasts remodel microenvironments by secreting matrix proteins that are slowly calcified.
(E) hFOB osteoblasts secrete osteocalcin after being plated on glass. By day 7, the matrix is thick (F) and compliant with Eosteo 25–40 kPa (G) based
on measurements made by AFM.nonoverlapping optimum inmatrix stiffness after 1 week is
seen for the specification of each of the three lineages.
The intensity scale is normalized to the primary cells
C2C12 and hFOB, which also show optimal matrix elastic-
ities for expression (MyoD and CBFa1, respectively) and
further exhibit an elevated baseline in expression on sub-
optimal matrices. In other words, primary cells appear
preprogrammed to express an elevated basal level of
the characteristic markers regardless of matrix. In con-
trast, MSCs express no significant levels of the lineage
markers, except of course on the optimal matrices. Bleb-
bistatin again blocks expression of all markers on all ma-
trices (Figure 3C; gray curve), consistent with an inhibition
of the cell’s ability to feel and respond to its matrix.Induction Media Adds to Inductive Matrix
before Lineage Commitment
In culture, differentiation of MSCs is usually induced by
addition of specific soluble factors, such as Dexametha-
sone, which can permeate cell membranes and can, in
principle, directly activate lineage programs. The myo-
blast inductionmedia used here (MIM, Table S2) is already
known to promote myogenesis, with expression of MyoD,
Myogenin, and skeletal muscle myosin heavy chain (Gang
et al., 2004; Pittenger et al., 1999). Across the various elas-
tic matrices here, MIM induces MSCs to express high
basal levels of MyoD that approach the constitutive ex-
pression levels of C2C12 myoblasts (Figure 4A). A clear
peak for MSC + MIM on the myogenic matrix (8–17 kPa)Cell 126, 677–689, August 25, 2006 ª2006 Elsevier Inc. 681
Figure 3. Protein and Transcript Profiles Are Elasticity Dependent under Identical Media Conditions
(A) The neuronal cytoskeletal marker b3 tubulin is expressed in branches (arrows) of initially naive MSCs (>75%) and only on the soft, neurogenic
matrices. The muscle transcription factor MyoD1 is upregulated and nuclear localized (arrow) only in MSCs on myogenic matrices. The osteoblast
transcription factor CBFa1 (arrow) is likewise expressed only on stiff, osteogenic gels. Scale bar is 5 mm.
(B) Microarray profiles of MSCs cultured on 11 or 34 kPa matrices, with expression normalized first to actin and then to expression of committed
C2C12 myoblasts and hFOB osteoblasts.
(C) Fluorescent intensity of differentiationmarkers versus substrate elasticity reveals maximal lineage specification at theE typical of each tissue type.
Average intensity is normalized to peak expression of control cells (C2C12 or hFOB), for which only fits to Equation S3 are shown. Blebbistatin blocks
all marker expression in MSCs.is evident and suggests a statistically similar level of line-
age commitment for MSCs and C2C12 cells.
Addition of blebbistatin to persistently block NMM II ac-
tivity (i.e., MIM + blebbistatin) still blocks cell spreading,
but MyoD expression is found to be significantly above
baseline. However, expression lacks the usual matrix-
induced peak expression near Emuscle (Figure 4A). Thus,
matrix-driven expression changes appear to depend on
active NMM II, while induction media stimulates basal-682 Cell 126, 677–689, August 25, 2006 ª2006 Elsevier Inc.level myogenesis regardless of cell shape or active
NMM II. Additionally, when blebbistatin is added to
MSCs that are allowed to first spread and become spindle
shaped for 24 hr on Emuscle gels (see Figure 1B), MSCs
maintain their morphology (Figure S2), but the blebbistatin
suppresses MyoD expression. Subsequent washout of
the drug 72 hr later allows full recovery of MyoD expres-
sion. When taken together, (1) lack of MyoD expression
by spindle-shaped blebbistatin-treatedMSCs, (2) induced
Figure 4. Induction Media and Matrix Reveal Synergy as well as Lineage Plasticity and Eventual Commitment
(A and B) After 1 week in culture in standard MSC growth media, fluorescent intensities of MyoD1 and CBFa1 in MSCs reveal little to no expression
except at peaks near Emuscle and Eosteo, respectively. When myogenic or osteogenic induction media (MIM or OIM) is added, MyoD1 or CBFa1
expression occurs on all substrates, with peak expression at levels near those of control cells, indicating a synergy of matrix and media induction.
When cultured in both MIM and blebbistatin (filled symbol and dashed line), MSCs also express a constant level of MyoD. Curve fits throughout
use Equation S3.
(C) Western blots confirm lineage specification with matrix or supplemented media alone: when normalized to actin, CBFa1, and MyoD expression
reach control levels only when both matrix stiffness and media are conducive for specification.
(D and E) MSCs plated on neurogenicmatrices in standard growthmedia were cultured for 1 or 3 weeks prior to having their media changed toMIM or
OIM for an additional week (open data points). After mixed induction for 1 week + 1 week, MSC expression of b3 tubulin is seen to decrease while
MyoD1 or CBFa1 expression increases, thus creating trans-differentiated cell types when compared to cultures in normal growth media (closed data
points). However, after 3 weeks of matrix induction, MSCs become committed and unperturbed by 1 week in trans-induction media. Cells remain
branched and express the same high levels of b3 tubulin with little to no significant expression of MyoD or CBFa1. Fluorescence intensities
(mean ± SEM) were measured for dual-labeled cells.expression in MIM of unspread cells, and also (3) MIM-
induced MyoD expression on ‘‘incorrect’’ matrices (e.g.,
MSC + MIM on 1 kPa or 34 kPa gels) all imply that active
NMM II is indeed important to lineage specification inde-
pendent of cell shape. It is also clear, however, that on
ECM with the ‘‘correct’’ elasticity, active NMM IIs, and
soluble induction factors synergistically combine formore complete myogenesis, as calibrated against com-
mitted cells (i.e., C2C12).
Similar results as above are found with a standard oste-
oblast induction media (OIM), which is known to promote
cytoskeletal rearrangement and alkaline phosphatase
production (Jaiswal et al., 1997; McBeath et al., 2004).
Increased basal expression of CBFa1 occurs on allCell 126, 677–689, August 25, 2006 ª2006 Elsevier Inc. 683
substrates, and there is still a clear optimum for lineage
specification on the stiffest, osteogenic gels (Figure 4B).
The quantitative immunofluorescence assessments
above are confirmed by Western blots and clearly high-
light the precommitted nature of C2C12 and hFOB ‘‘con-
trol cells’’ as well as both the constitutive and additive
effects of induction media on MSCs (Figure 4C).
The results above indicate that cells grown on a matrix
that is, for example, neurogenic due to its softness
(1 kPa), can be induced by soluble factors (MIM or OIM)
to also express myogenic or osteogenic factors yielding
a ‘‘mixed MSC phenotype.’’ To assess commitment due
to matrix alone, MSCs were preplated in standard growth
media for either 1 or 3 weeks on the soft neurogenic gels
and then switched to the different induction media. With-
out the added induction media, cells stably express the
neurogenic marker b3 tubulin at a constant level from
1 to 4 weeks (Figures 4B and 4D; closed points). However,
when either MIM or OIM is added after 1 week, a further
week of culture reduces b3 tubulin levels by about half
and increases negligible MyoD levels several-fold (Figures
4B and 4D; open points). These ‘‘mixed phenotype’’MSCs
display multiple lineage signals, albeit at low levels, rather
than creating twoMSCpopulations committed to different
lineages in the same culture, as cells at this plating con-
centration are very slow to proliferate, even in growth
media (McBeath et al., 2004). In contrast, when MSCs
are preincubated for 3 weeks on neurogenic matrices
before switching media for a final week, MSCs are less
plastic and more firmly committed to their matrix-defined
lineage: high levels of b3 tubulin remain statistically the
same, and CBFa1 is essentially undetectable. Similar re-
sults are also observed for matrix changes where MSCs,
replated from stiff to soft matrices, maintain their original
specification when given sufficient incubation time (not
shown). Slight perturbations under delayed mixed induc-
tion might be real (e.g., MyoD upregulation in Figure 4D),
since plasticity of ‘‘differentiated’’ cell types has been
demonstrated in various systems with (a) chemical ago-
nists that trans-differentiate myotubes (Rosania et al.,
2000), (b) transfected transcription regulators that trans-
differentiate fibroblasts to myoblasts (Davis et al., 1987),
and (c) classical growth factor pathways that trans-differ-
entiate myotubes to osteocytes (Katagiri et al., 1994).
Myosins in MSCs Couple Expression to Matrix
Stiffness and Reveal a Key Role for NMM IIs
Forces generated and/or imposed on the cell’s actin cyto-
skeleton have been postulated to influence differentiation
(Engler et al., 2004a; Hinz et al., 2001; McBeath et al.,
2004), but no past reports have hinted at strong, tissue-
directed feedback of microenvironment elasticity on myo-
sin expression or stem cell lineage specification. Cellular
tension must be modulated by matrix stiffness, with force
transmission occurring via focal adhesions. As described
in the introduction and supported by the blebbistatin and
ML7 results above, the likely generators of force are the
nonmuscle myosin II isoforms. We indeed find that these684 Cell 126, 677–689, August 25, 2006 ª2006 Elsevier Inc.and a number of myosin transcripts are not only ex-
pressed in naive MSC but also upregulated on stiffer
gels (11 and 34 kPa) when compared to softer matrices
(Figure 5A; left). Western blots and immunofluorescent im-
aging both confirm array results and show that NMM IIB is
up more than 2-fold relative to myosin levels before differ-
entiation (Figures 5B and 5C) on stiff matrices but is down-
regulated on the softest substrates. It is also found that
induction media has comparatively little effect on these
stiffness-responsive expression profiles (Figure 5C). The
kinetics of NMM IIB imply that it generates higher force
than NMM IIA (Rosenfeld et al., 2003) since it spends
a greater amount of time strongly attached to actin. We
therefore speculate that as matrix stiffness increases,
the cell alters its nonmuscle myosin expression in order
to generate greater forces on its actin cytoskeleton, which
would be necessary to deform a stiffer matrix.
Select myosin genes appear more matrix sensitive than
others based on microarray data clustered by RNA varia-
tion (Var) (Figure 5A; left). Western blots confirm the varia-
tion; NMM IIB expression is more sensitive to matrix elas-
ticity than NMM IIA expression (Figure 5B). The blots also
confirm (1) myogenic commitment with requisite upregu-
lation of both MyoD and the intermediate filament protein
desmin (Weitzer et al., 1995) and (2) osteogenic commit-
ment with CBFa1. Immunofluorescence images of NMM
IIA not only reinforce microarray and blot results but
further reveal changes in myosin organization (Figure 5C;
inset images). On soft matrices, NMM II staining is diffuse.
On moderately stiff matrices, myosin striations emerge
that have an appearance previously described as premyo-
fibrillar structures in committed myoblasts (Sanger et al.,
2002). Spacing between these nascent striations is the
same for MSCs and age-matched C2C12 myocytes
(1.0 ± 0.3 mm), and while these striations are lost on the
stiffest matrices where stress fibers predominate, NMM
II striation appears consistent with nonmuscle myosin
organization (Verkhovsky et al., 1995). However, the
striation period is clearly smaller than the spacing set by
myogenic molecular ‘‘rulers’’ such as titin (TTN in Fig-
ure 3B) (Sanger et al., 2002), indicating that MSCs have
not assembled mature myofibrils after a week in culture.
This is consistent with low levels of skeletal musclemyosin
transcript (MHC2A; Figure 5A) and protein (Figure S1B),
emphasizing the fact that these sparse cultures of
mononucleatedMSCs can become committed but remain
early myoblasts.
Chronic inhibition of NMM II’s ATPase activity with bleb-
bistatin (Limouze et al., 2004; Straight et al., 2003) not only
inhibits morphological changes of MSCs on various matri-
ces (Figures 1Bi and 1Bii) but also reduces transcripts
levels for NMM IIA (to 50%), IIB (to 8%), and IIC (to 3%)
(Figure 5A; right). Importantly, myosins that are not directly
affected by blebbistatin treatment changed to a lesser
extent from control levels, with one-third of the panel
showing no change (MYO5B, MYO1A, MLC3, andMYH3).
This highlights the specificity of a key mechanosensing
feedback loop between blebbistatin-inhibited activity
Figure 5. Multiple Myosins Are Expressed by MSCs Depen-
dent on Matrix and Contractility
(A) A range of myosin transcripts show graded sensitivity to stiffness
(Var) and an overall average expression (Avg) that is upregulated for
MSCs on stiffer matrices. Blebbistatin downregulates many myosin
transcripts, especially those for NMM IIB, IIC, and myosin VI, which
are directly inhibited.
(B) Immunoblots show large variations with substrate stiffness in NMM
IIB, C, and various differentiation markers: neurogenic (b3 tubulin),
myogenic (MyoD and Desmin), and osteogenic markers (CBFa1).
These also show sensitivity to blebbistatin and ML7.
(C) Immunofluorescence of NMM IIB (mean ± SEM) shows similar stiff-
ness sensitivity and does not change with induction media (i.e. MIM or
OIM), but blebbistatin inhibits expression10-fold (dashed line) based
on Western blots. Inset images of NMM II highlight organization of
NMM II with striations (arrowheads) on Emuscle matrix (11 kPa) and
stress fibers on the stiffer matrix (34 kPa). Scale bar is 5 mm.and NMM II expression. Western blots confirm similar iso-
form sensitivity at the protein level to blebbistatin and also
to ML7, an inhibitor that also inhibits the NMM II’s through
its inhibition of MLCK. NMM IIA expression only slightly
downregulates, while NMM IIB expression drops about
10-fold to levels comparable toMSCs on soft gels (Figures
5B and 5C), and NMM IIC is no longer detectable. The
downregulation suppresses both striation and stress-fiber
formation, consistent with a relaxation effect on blebbista-
tin-treated cells (Griffin et al., 2004) as well as the crosstalk
between nonmuscle myosin II activity and morphogenetic
and phenotypic specification. On soft gels, cells generally
display less cytoskeletal organization (Engler et al., 2004a;
Flanagan et al., 2002), as reinforced with results below.
Both blebbistatin andML7 suppress expression of key lin-
eagemarkers (Figures 1C and 5B), consistent with NMM II
activity, ultimately regulating lineage marker profiles in
addition to its own expression.
MSC Focal Adhesions Increase with NMM II-Based
Contractility and Both Increase with Matrix Stiffness
Stiff substrates promote focal adhesion growth and elon-
gation, based on paxillin immunofluorescence (Figure 6A).
Consistent with this observation, stiff substrates led to in-
creased expression of focal adhesion components (Table
S4), including nonmuscle a-actinin, filamin, talin, and focal
adhesion kinase (FAK or PTK2). These results with MSCs
are fully consistent with the earliest reports of the sub-
strate-stiffness responses of differentiated cells (Pelham
and Wang, 1997). We also find that MSCs feel into matri-
ces on the length scales of their adhesions and not much
deeper. This is based on the finding that a thin soft gel on
glass (h  0.5–1 mm) fosters cell spreading similar to that
of cells on stiffer gels (Figure S3). Actin assembly follows
the trends in adhesion assembly (Figure 6B), which
Figure 6. Adhesions Grow and Cytoskeletal Organization In-
creases with Substrate Stiffness
(A) Paxillin-labeled adhesions grow from undetectable diffuse ‘‘con-
tacts’’ on neurogenic, soft gels (1 kPa) to punctate adhesions on stiffer,
myogenic gels (11 kPa). On the stiffest, osteogenic gels (34 kPa), the
adhesions are long and thin and slightly more peripheral than they ap-
pear on glass.
(B) F-actin organization shows a similar trend, from diffuse on soft gels
to progressively organized on stiffer substrates (as stress fibers). Scale
bar is 20 mm.Cell 126, 677–689, August 25, 2006 ª2006 Elsevier Inc. 685
generalizes the matrix-driven assembly of the cytoskele-
ton to MSCs. NMM II is already known to promote the as-
sembly of focal adhesions (Conti et al., 2004), and so the
prominent adhesions on stiffer substrates is consistent
with greater activity of NMM II.
Focal adhesions provide MSCs the necessary force
transmission pathways to ‘‘feel’’ their microenvironment
through actin-myosin contractions. This pulling or con-
tractility by cells can be measured as a mean cellular pre-
stress, s, that balances the traction stresses, t, exerted on
the gel by the cell (Wang et al., 2002) (Figure 7). Consistent
withmonotonic increases in focal adhesions versusmatrix
stiffness, the prestress s for MSCs, C2C12 myoblasts,
and hFOB osteoblasts all show a linear increase versus
matrix stiffness (Figure 7; top). Blebbistatin prevents any
of the cells from developing either a prestress s (Griffin
et al., 2004) or—asmeasured by a single-cell micropipette
aspiration method (Figure S4)—a significant cell cortex
stiffness k on any matrix (Figure 7; bottom, open points).
The simplistic measures here of cell mechanics demon-
strate that stiffer matrices produce stiffer and increasingly
tensed cells.
Figure 7. Stiffer Matrices Produce Stiffer and More Tense
Cells
Cell prestress, s, in both MSCs and control cell lines increases linearly
with substrate elasticity, E. Inset image shows a myoblast (outlined)
displacing beads embedded in the gel (white arrows) that equates to
a strain field represented by the color map (red is high strain). Scale
bar is 10 mm. Lower plot shows membrane cortical stiffness measured
bymicropipette aspiration increases with gel stiffness, but blebbistatin
treatment softens all cell membranes >3-fold. Middle inset shows
mean intracellular strain, 3in ( s / k), versus the mean extracellular
strain, 3out ( t / E), fit to a power law (i.e., 3in = B 3outb) for all cell types.
The trend implies larger deformation within the cell on stiff matrices
and larger deformation in the matrix on softer matrices. Results shown
are Mean ± SEM.686 Cell 126, 677–689, August 25, 2006 ª2006 Elsevier Inc.DISCUSSION
Lineage specification of naive stem cells induced by solu-
ble stimuli has been well described (Gang et al., 2004;
Jaiswal et al., 1997; McBeath et al., 2004; Pittenger
et al., 1999), but the results here report a strong and pre-
viously undocumented influence of microenvironment
stiffness on stem cell specification. Naive stem cells ex-
press no baseline levels of lineage-specific markers, in
contrast to committed cells (myoblasts and osteoblasts
in Figures 3B, 3C, 4A, and 4B), so that—against this low
baseline—MSCs are seen to respond dramatically in
both morphology and lineage to the matrix presented.
The responses here do not include remodeling the micro-
environment; for example, collagen-I production is very
low inMSCs on soft matrices <11 kPa (see downregulated
matrix transcripts; Figure 1C), whereas on 34 kPa
matrices, MSCs appear somewhat more secretory (e.g.,
BMP1-5 and COL3A1), consistent with the secreting
hFOB osteoblasts (Figure 2E) (Kong et al., 2005). This pas-
sive, initial response of MSCs to the microenvironment
would be expected from a multipotent stem cell awaiting
instruction.
MSC plasticity is evident in the initial responsiveness to
conflicting signals from soft matrix and media (Figures 4D
and 4E), consistent with passive responsiveness to inputs.
The slow time course of true lineage commitment here
contrasts with the rapid and controversial morphological
changes with DMSO (Dinsmore et al., 1996; Woodbury
et al., 2002). Here, MSCs spread with time, and branching
increases on soft matrices (Figure 2B), indicating an active
process. In contrast, fibroblasts (Figure 2B), myoblasts
(Engler et al., 2004a), and osteoblasts (not shown) do
not appear branched on soft substrates. The committed
differentiation of the latter cell types (epigenetic) to spec-
ified lineages precludes, for example, the reprogramming
ofmyosin levels with changes ofmatrix (Table S4). In com-
parison, MSCs prove far more responsive, and while evi-
dence for roles of nonmuscle myosins in MSCs feeling
the matrix is suggestive, more work on mechanism is
clearly needed.
Possible Implications for Stem Cell Therapies
Regenerative applications of stem cells are being investi-
gated for a number of tissues, including clinical trials for
postmyocardial infarction patients (Lee et al., 2004). Effi-
cacy appears uncertain or mixed (Murry et al., 2004),
and recent findings have raised the possibility that the in-
jured microenvironment loses compliance with fibrotic
scarring, producing a noninducing environment (Berry
et al., 2006) that, as we show here, stem cells cannot suf-
ficiently remodel. The results here suggest the need for
optimizing matrix elasticity to foster regeneration, which
seems applicable to a number of regenerative applica-
tions of stem cells such as cardiomyoplasty, muscular
dystrophy, and neuroplasty. Any starting point for such
approaches must include characterization of the mecha-
nosensitivity of the stem cell of interest to matrix elasticity.
The results of this study also suggest that ‘‘precommit-
ting’’ stem cells to a specific lineage via appropriate in vitro
matrix conditions might partially overcome an inappropri-
ate in vivo microenvironment.
EXPERIMENTAL PROCEDURES
Cell Culture
Human Mesenchymal Stem Cells (MSCs; Osiris Therapeutics; Balti-
more, MD), human osteoblasts (hFOBs, ATCC), primary human skin fi-
broblasts (1F7) (Engler et al., 2004a), and murine myoblasts (C2C12s,
ATCC) were cultured in normal growth media listed in Table S2. To
chemically induce differentiation, cells were placed in the appropriate
induction media also listed. All cells were used at low passage num-
bers, were subconfluently cultured, and were plated at 103 cells/
cm3 for experiments. Cells were cultured for 7 days or cultured and re-
plated for a specified time unless otherwise noted. All chemicals were
purchased from Sigma (St. Louis, MO) unless otherwise noted. To in-
hibit proliferation, cells were exposed tomitomycin C (10 mg/ml) for 2 hr
and washed three times with media prior to plating. Blebbistatin
(50 mM, EMD Biosciences), a nonmuscle myosin II inhibitor, was ap-
plied with every media change and was stable in culture media for
up to 48 hr, as determined by thin-layer chromatography. Y27632
(10 mM, EMD Biosciences), a ROCK inhibitor, and ML7 (10 mM; EMD
Biosciences), a myosin light chain kinase inhibitor, were also added
to inhibit specification.
Substrate Preparation
Cells were plated on variably compliant polyacrylamide gels, accord-
ing to a previously established protocol by Pelham and Wang (Pelham
and Wang, 1997), creating gels that were 70–100 mm thick as mea-
sured by microscopy. To produce thin gels, a protocol from Engler
and coworkers was used (Engler et al., 2004b). Type 1 collagen was
used at 0.25–1 mg/cm2 (BD Biosciences), as quantified using fluores-
cent collagen for calibration (per Engler et al., 2004a).
AFM for Matrix Elasticity and Cell Mechanics Methods
Substrate elasticity was characterized per Engler et al. (2004b). For
matrix secreted by hFOB osteoblasts, cells were plated for 7 days
on glass substrates to allow matrix deposition. Samples were placed
on an Asylum 1-D atomic force microscopy (AFM) (Asylum Research;
Santa Barbara, CA) and indented by a pyramid-tipped probe (Veeco;
Santa Barbara, CA) with a constant, ksp60 pN/nm. Force-indentation
profiles were obtained immediately adjacent to a cell, and each inden-
tation profile was fit up to the point at which probe indentation into the
secreted matrix stopped with a Hertz cone model (Rotsch et al., 1999).
Details of the cell mechanics measurements can be found in the Sup-
plemental Data.
Lineage Specification Assays
Morphological Changes and Immunofluorescence
Changes in cell shape (<4 days), especially the development of
branches (Flanagan et al., 2002) or spindle-like morphologies (Engler
et al., 2004a), were quantified either by the number of membrane
branches per mm of cell or by a ‘‘spindle factor,’’ the major/minor
cell axis, respectively. Cells also were stained with lineage-specific an-
tibodies: myogenesis with Myogenesis Differentiation Protein 1 (MyoD1;
Chemicon) and desmin (Sigma); osteogenesis with Core Binding Fac-
tor a1 (CBFA1; Alpha Diagnostic International) and osteocalcin (EMD
Biosciences); and neurogenesis with phosphorylated and dephos-
phorylated Neurofilament Heavy chain (NFH; Sternberger Monoclo-
nal), Neurofilament Light chain (NFL; Sigma), nestin (BD Pharmagen),
Microtubule Associated Protein 2 (MAP2; Chemicon), and b3 tubulin
(Sigma) along with paxillin (Chemicon), skeletal muscle myosin heavy
chain (Zymed), nonmuscle myosin IIA and IIB (Sigma), IIC (courtesy
of R. Adelstein, NIH), and rhodamine-labeled phalloidin. Cells werefixed, blocked, permeabilized, and labeled with Hoechst 33342, pri-
mary and secondary antibodies, or 60 mg/ml TRITC-phalloidin.
Cell morphology and fluorescently labeled cells were examined on
a TE300 inverted epifluorescent Nikon or Olympus (TIRF) microscope,
imaged on aCascadeCCD camera (Photometrics), and quantifiedwith
Scion Image. Intensity analysis was displayed as the fold-change of
the whole cell average above background fluorescence and staining
with secondary antibodies only. For Figure 3C only, however, intensi-
ties were then normalized by the maximal expression of the positive
control cell. For Figure 5C only, intensities were then normalized by
the expression of initially isolated MSCs to show a change from the ini-
tial myosin level.
Western Blotting
Cells were plated on gels on 45 3 50 sq. mm coverslips to obtain
enough cells for Western blotting. Cells were permeablized (1:1 of
10% SDS, 25 mM NaCl, 10 nM pepstatin, and 10 nM leupeptin in dis-
tilled water and loading buffer), boiled for 10 min, and placed in reduc-
ing PAGE (Invitrogen). Proteins were transferred onto nitrocellulose,
blocked, and labeled via HRP-conjugated antibodies (Biorad). All
Westerns were run in duplicate, along with an additional blot for actin
and Coomassie blue staining to ensure constant protein load among
samples.
Oligonucleotide Array Assays
Total RNA (3–5 mg) was obtained from MSCs cultured on gel sub-
strates of varying stiffness, as well as C2C12 myoblasts and hFOB
osteoblasts, using an ethanol-spin column extraction. Samples were
labeled with an Ampolabeling Linear Polymerase Reaction kit (Super-
Array Bioscience) and hybridized to custom oligonucleotide arrays.
Chemiluminescent signals were detected on Biomax Film (Kodak).
Arrays were first corrected for array background fluorescence and nor-
malized to a control gene, b-actin. Data for genes indicating mesen-
chymal origin (Table S1) along with genes for contractile, adhesive,
and activating proteins (Table S4) were displayed only as this actin-
normalized value. Genes for neuro-, myo-, and osteogenesis, how-
ever, were further analyzed by either (1) comparing MSCs on gels to
initially isolated MSCs (Figure 1C and Table S3; i.e., [MSC on specific
gel]/[initially isolated MSC]) or (2) normalizing MSC expression on gels
to control cell expression level (Figure 3B and Table S3; i.e., [MSC on
specific gel]/[control cell]).
Supplemental Data
Supplemental Data include four figures, four tables, experimental pro-
cedures, and references and can be found with this article online at
http://www.cell.com/cgi/content/full/126/4/677/DC1/.
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